CN Patent

CN1290264A — 三嗪类血管生成抑制剂

Assigned to Abbott Laboratories · Expires 2001-04-04 · 25y expired

What this patent protects

式(Ⅰ)化合物或其可药用盐或者其前药,用于治疗由血管生成引起或恶化的疾病。本发明还涉及含有这些化合物的药物组合物和抑制哺乳动物血管生成的方法。

USPTO Abstract

式(Ⅰ)化合物或其可药用盐或者其前药,用于治疗由血管生成引起或恶化的疾病。本发明还涉及含有这些化合物的药物组合物和抑制哺乳动物血管生成的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN1290264A
Jurisdiction
CN
Classification
—
Expires
2001-04-04
Drug substance claim
No
Drug product claim
No
Assignee
Abbott Laboratories
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.